Table 1 Staphylococcus aureus carriage among medical students in published papers

1994

Stubbs et al. [7]

Australia

N = 808

261/808 (30%)

68/193 (35%)

252/615 (40%)

0

0

0

2004

Berthelot et al. [8]

France

N = 124

34/124 (27%)

N/A

N/A

1/124) (1%)

N\A

N/A

2007

Güçlü et al. [9]

Turkey

N = 179

50/179 (28%)

12/179 (15%)

38/179 (76%)^a

N/A

N/A

N/A

2007

Higuchi et al. [10]

Japan

N = 98

36/98 (36%)

N/A

N/A

0

0

0

2007

Adesida et al. [11]

Nigeria

N = 182

26/182 (14%)

N/A

N/A

0

0

0

2008

Baliga et al. [12]

India

N = 50

44/50 (88%)

N/A

N/A

12/50 (24%)

N/A

N/A

2009

Slifka et al. [13]

USA

N = 182

62/182 (34%)

N/A

N/A

5/182 (3%)

2/95(2%)

3/87 (3%)

2011

Ma et al. [14]

China

N = 2103^b

212/2103 (10%)

N/A

N/A

22/2103 (1%)

N/A

N/A

SCCmec I, ST88 PVL- (n = 1);

SCCmec II, ST5 PVL+ (n = 1) PVL- (n = 1);

SCCmec III, ST 239 PVL- (n = 1);

SCCmec IVa, ST88 PVL+ (n = 5), PVL-(n = 3), ST30 (n = 1), ST1, PVL+ (n = 1); SCCmec IVn,ST59 (n = 2); SCCmec IVc, ST30,PVL+ (n = 2)

SCCmec V, ST59 PVL+ (n = 2), ST90 PVL- (n = 1); non typable (n = 1)

2011

Roberts et al. [15]

Canada

N = 61^c

N/A

N/A

N/A

13/61 (21%)

N/A

N/A

SCCmec IV, ST1159 (n = 1);

12 NT*^,HA [ST8,ST30 (n = 3), ST39, ST45, ST101, ST109, ST256 (n = 2), ST 1474, ST1474]

2011

Chamberlain et al. [16]

USA

N = 132

62/132 (47%)

N/A

N/A

7/132 (5%)

N/A

N/A

2011

Kitti et al. [17]

Thailand

N = 200

30/200 (15%)

N/A

N/A

2/200 (1%)

N/A

N/A

SCCmec II (n = 2)

2012

Gualdoni et al. [18]

Austria

N = 79

20/79 (25%)

N/A

N/A

0

N/A

N/A

2012

Bettin et al. [19]

Colombia

N = 387

96/387 (25%)

N/A

N/A

6/387 (2%)

N/A

N/A

SCCmec I, PVL- (n = 1); SCCmec IV, PVL+ (n = 5) ^CA

2012

Mahmutović Vranić et al. [20]

Bosnia

N = 387

39/387 (11%)

N/A

N/A

0

N/A

N/A

2012

Chen et al. [21]

Taiwan

N = 322

55/322 (17%)

24/167 (14%)

31/155 (20%)

7/322 (2%)

4/167 (2%)

3/155 (2%)

SCCmec IV, ST59 (n = 2), N/A MLST (n = 4), PVL – (n = 6)^CA

SCCmec V_T, ST59, PVL+ (n = 1)^CA

2012

Syafinaz et al. [22]

Malaysia

N = 209

21/209 (10%)

14/111 (13%)

7/97 (7%)

0

0

0

2013

Bellows et al. [23]

USA

N = 94

15/94 (16%)

3/42 (7%)

12/52 (23%)^a

3/94 (3%)

0

3/52 (6%)

2013

Cirković et al. [24]

Serbia

N = 533

N/A

N/A

N/A

2/533 (0.4%)

N/A

N/A

SCCmec IV, ST80^CA

SCCmec V,ST152^CA

2013

Trépanier et al. [25]

Canada

N = 497^d

N/A

N/A

N/A

1/497 (0.2%)

1/247 (0.4%)

0

2014

Treesirichod et al. [26]

Thailand

N = 128

42/127 (33%)

38/128 (30%)

2^nd sample 39/128 (31%)

3^rd sample 50/127 (39%)^a

0

0

0

3 prospective samples

2015

Zakai et al. [27]

Saudi Arabia

N = 182

60/182 (32%)

32/32 (100%)

28/150 (19%)

10/182 (5%)

0/32

10/150 (7%)

2015

Collazos Marín et al. [28]

Colombia

N = 216

54 (25%)

N/A

N/A

9/216 (4%)

N/A

N/A

4/9 (44%)^CA

2015

Ho et al. [29]

China

N = 1149

526/1149 (45%)

N/A

N/A

6/1149 (1%)

N/A

N/A

SCCmec IV,t437 (n = 3)^CA :PVL+ (n = 1)

t11642 (n = 1)^CA, t1081 (n = 1)^HA, t267 (n = 1)^HA

2016

Baek et al. [30]

South Korea

N = 159^c

N/A

N/A

N/A

5/159 (3%)

N/A

SCCmec IV (n = 4)

SCCmec I (n = 1)

2016

Okamo et al. [31]

Tanzania

N = 314

66/314 (21%)

33/166 (20%)

33/148 (22%)

1/314 (0.3%)

N/A

N/A

2016

Ansari et al. [32]

Nepal

N = 200

30/200 (15%)

N/A

N/A

8/200 (4%)

N/A

N/A